These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 24622113)
1. Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. Gurbel PA; Tantry US JACC Heart Fail; 2014 Feb; 2(1):1-14. PubMed ID: 24622113 [TBL] [Abstract][Full Text] [Related]
2. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA; Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044 [TBL] [Abstract][Full Text] [Related]
3. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
4. Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications. Kim JH; Shah P; Tantry US; Gurbel PA Curr Heart Fail Rep; 2016 Dec; 13(6):319-328. PubMed ID: 27815681 [TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy for heart failure in sinus rhythm. Subramaniam V; Davis RC; Shantsila E; Lip GY Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305 [TBL] [Abstract][Full Text] [Related]
6. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Lip GY; Ponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marin F; Lane DA; Eur J Heart Fail; 2012 Jul; 14(7):681-95. PubMed ID: 22611046 [TBL] [Abstract][Full Text] [Related]
7. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives]. Scardi S; Mazzone C Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1. Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077 [TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis. Rengo G; Pagano G; Squizzato A; Moja L; Femminella GD; de Lucia C; Komici K; Parisi V; Savarese G; Ferrara N; Perrone-Filardi P; Leosco D PLoS One; 2013; 8(1):e52952. PubMed ID: 23301006 [TBL] [Abstract][Full Text] [Related]
10. Do anticoagulants or antiplatelet drugs have a role in treating heart failure in the absence of atrial fibrillation? Gouda P; Ezekowitz JA Clin Pharmacol Ther; 2013 Oct; 94(4):435-8. PubMed ID: 24048238 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Lip GY; Gibbs CR Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic Therapy for Heart Failure in Sinus Rhythm - A Concise Review. Sharma R; Subedi A S D Med; 2024 May; 77(5):213-219. PubMed ID: 39012774 [TBL] [Abstract][Full Text] [Related]
13. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study. Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375 [TBL] [Abstract][Full Text] [Related]
14. The Role of Antithrombotic Therapy in Heart Failure. Chrysohoou C; Magkas N; Antoniou CK; Manolakou P; Laina A; Tousoulis D Curr Pharm Des; 2020; 26(23):2735-2761. PubMed ID: 32473621 [TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials. Ntaios G; Vemmos K; Lip GY Int J Stroke; 2019 Dec; 14(9):856-861. PubMed ID: 31526132 [TBL] [Abstract][Full Text] [Related]
16. A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis. Sulaica EM; Macaulay TE; Helbing RR; Abo-Aly M; Abdel-Latif A; Wanat MA Heart Fail Rev; 2020 Mar; 25(2):207-216. PubMed ID: 31256317 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulation in heart failure: current status and future direction. Gheorghiade M; Vaduganathan M; Fonarow GC; Greene SJ; Greenberg BH; Liu PP; Massie BM; Mehra MR; Metra M; Zannad F; Cleland JG; van Veldhuisen DJ; Shah AN; Butler J Heart Fail Rev; 2013 Nov; 18(6):797-813. PubMed ID: 22987320 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal. Prom R; Usedom JE; Dull RB Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves. Eikelboom JW; Hart RG Am J Hematol; 2012 May; 87 Suppl 1():S100-7. PubMed ID: 22389052 [TBL] [Abstract][Full Text] [Related]
20. Role of antithrombotic agents in heart failure. Cleland JG; Mumtaz S; Cecchini L Curr Cardiol Rep; 2012 Jun; 14(3):314-25. PubMed ID: 22467260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]